Elizabeth Masson-Hurlburt

2019

In 2019, Elizabeth Masson-Hurlburt earned a total compensation of $671.4K as Executive Vice President and Head of Clinical Operations at CorMedix, a 60% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$67,200
Option Awards$298,504
Salary$280,000
Other$25,734
Total$671,438

Masson-Hurlburt received $298.5K in option awards, accounting for 44% of the total pay in 2019.

Masson-Hurlburt also received $67.2K in non-equity incentive plan, $280K in salary and $25.7K in other compensation.

Rankings

In 2019, Elizabeth Masson-Hurlburt's compensation ranked 10,847th out of 13,971 executives tracked by ExecPay. In other words, Masson-Hurlburt earned more than 22.4% of executives.

ClassificationRankingPercentile
All
10,847
out of 13,971
22nd
Division
Manufacturing
4,387
out of 5,695
23rd
Major group
Chemicals And Allied Products
1,710
out of 2,194
22nd
Industry group
Drugs
1,465
out of 1,880
22nd
Industry
Pharmaceutical Preparations
1,081
out of 1,392
22nd
Source: SEC filing on November 4, 2020.

Masson-Hurlburt's colleagues

We found four more compensation records of executives who worked with Elizabeth Masson-Hurlburt at CorMedix in 2019.

2019

Khoso Baluch

CorMedix

Chief Executive Officer

2019

Phoebe Mounts

CorMedix

General Counsel

2019

Robert Cook

CorMedix

Chief Financial Officer

2019

John Armstrong

CorMedix

Executive Vice President for Technical Operations

News

You may also like